Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Management of Heart Failure in Patients Nearing the End of Life - There is So Much More To Do

Citation:

Cardiac Failure Review 2015;1(1):31–4

The Management of Heart Failure with Preserved Ejection Fraction

Citation:

Cardiac Failure Review 2015;1(1):11–5

The Bi-directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes – A review of the Epidemiology and Outcomes

Citation:

Cardiac Failure Review 2015;1(1):8–10

The Brugada Syndrome – Diagnosis, Clinical Implications and Risk Stratification

Citation:

European Cardiology Review 2014;9(2):82–7